{"cluster": 43, "subcluster": 32, "abstract_summ": "Article highlight based on \u201cEffects of IgG and IgM autoantibodies on non-infected erythrocytes is related to ABO blood group in Plasmodium vivax malaria and is associated with anemia\" by Luiza Carvalho Mour\u00e3o et al.[Figure: see text]There is an urgent need to develop effective therapies for COVID-19.We report preliminary data providing evidence of complement activation in patients with COVID-19 with different degrees of respiratory failure.JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.In COVID-19, complement activation may contribute to hemostatic activation leading to pathological features such as microvascular injury and coagulopathy.Here, we urge immunologists and clinicians to consider the potential of targeting the complement system in these patients.", "title_summ": "COMPLEMENT ACTIVATION IN PATIENTS WITH COVID-19: A NOVEL THERAPEUTIC TARGETPathogenesis of COVID-19 from a cell biologic perspectiveThere Will be Blood()Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?: This paper is dedicated to Sofia Maione born during COVID-19 outbreak.The potential role of JAK inhibitors in the management of COVID-19.COVID-19, microangiopathy, hemostatic activation, and complement.HiJAKing SARS-CoV-2?Complement as a target in COVID-19?", "title_abstract_phrases": "The potential role of JAK inhibitors in the management of COVID-19.JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?: This paper is dedicated to Sofia Maione born during COVID-19 outbreak.[Figure: see text]Complement as a target in COVID-19?There is an urgent need to develop effective therapies for COVID-19.We report preliminary data providing evidence of complement activation in patients with COVID-19 with different degrees of respiratory failure.In COVID-19, complement activation may contribute to hemostatic activation leading to pathological features such as microvascular injury and coagulopathy.There Will be Blood()Article highlight based on \u201cEffects of IgG and IgM autoantibodies on non-infected erythrocytes is related to ABO blood group in Plasmodium vivax malaria and is associated with anemia\" by Luiza Carvalho Mour\u00e3o et al."}